INBRAIN Neuroelectronics key facts
- Operator of a medical device company intended to provide real-time precision neurology and resolution graphene intelligent neural systems.
- It has raised $94.5M; the latest was Early Stage VC ($50.0M) in Oct 2024.
- Notable investors include MedTech Innovator, European Union, INNVIERTE SICC, VSquared Ventures, CDTI Innvierte — 23 tracked in total.
- Status: Privately Held (backing).
Who backs INBRAIN Neuroelectronics
23+- ·The complete investor list: 23 names
- ·Watch INBRAIN Neuroelectronics: the Monday email on marks, rounds and moves
INBRAIN Neuroelectronics funding rounds
No funding rounds for INBRAIN Neuroelectronics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
INBRAIN Neuroelectronics investors
23 investors are on record for INBRAIN Neuroelectronics, including MedTech Innovator, European Union, INNVIERTE SICC and VSquared Ventures.
About INBRAIN Neuroelectronics
Operator of a medical device company intended to provide real-time precision neurology and resolution graphene intelligent neural systems. The company uses graphene to develop a full implantable platform with neural interfaces that can decode and modulate brain activity at high resolution, detecting therapy-specific biomarkers and triggering focal adaptive responses, enabling patients to obtain optimal therapeutic outcomes and using technology in neuro and bioelectronic applications.
- Sector
- Healthcare
- HQ
- Barcelona, Spain
- Founded
- 2020
- Employees
- 85
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
INBRAIN Neuroelectronics doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.